LataMed AI Corp. (LMED) Fair Value 2026

LMED · Software - Application ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.2 /10

32 fundamental signals · 2 models active

Value Trap Risk

LOW (36/100)

Quick Summary — As of 2026-10-07, LataMed AI Corp. (LMED) trades at $0.06, versus a $0.01 median fair value across its 2 active models — 87.6% below the current price. QOC: 4.2/10. Value Trap Risk: 36/100 (LOW). 2/13 models active.

Key Facts

Ticker
LMED
Price
$0.06
Quality Score
4.2/10
Value Trap Risk
36/100
Models Active
2/13
Last Updated
Strength: 2 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.2/10 signals weak fundamentals

Is LataMed AI Corp. (LMED) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, LataMed AI Corp. (LMED) appears overvalued as of : the median of 2 independent fair value estimates is $0.01, 87.6% below the current price of $0.06. Estimates range from $0.00 to $0.01. LMED scores 4.2/10 on fundamental quality and 36/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. LMED’s -87.6% gap is wider than that market norm, and the Software - Application sector median is -20.8%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy LataMed AI Corp. Stock in 2026? →

What Fair Value Does Each Model Give LMED?

2 Intrinsic Value Models vs. Current Price ($0.06)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · Medium Conviction
 $0.01 -76.8%
Intrinsic · Low Conviction
 $0.00 -98.5%

All Models Active

All 2 models are displayed above.

What Is LataMed AI Corp. (LMED) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, LataMed AI Corp.'s intrinsic value is estimated at $0.01. Trading at its current price of $0.06, the valuation engine raises significant caution: 2 of 2 models flag downside risk, projecting a median implied return of -87.6%.

What Do the Models Say About LMED?

2 of 13 models are currently active for LMED. All 2 active models suggest the stock trades above fair value. Taken together, their median fair value for LMED is $0.01 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does LMED Rank in Software - Application?

Among 261 Software - Application stocks, LMED ranks #224 by Quality of Company score. CirclFi's QOC score of 4.2/10 evaluates 32 fundamental signals. A score of 4.2 reflects mixed fundamentals.

See all Most Undervalued Software - Application Stocks →

LataMed AI Corp.'s positioning within the Software - Application segment means that R&D intensity plays an outsized role in fundamental analysis. The sector's unique characteristics — including AI/ML integration — shape both the opportunity set and risk profile.

Is LMED a Value Trap?

CirclFi's Value Trap algorithm assigns LMED a score of 36/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for LataMed AI Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, LataMed AI Corp. earns a quality score of 4.2/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

Models cluster within a tight range (+21.7% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LMED valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across LMED's 2 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy LataMed AI Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Software - Application Stocks Should You Also Analyze?

11 related Software - Application stocks with 13-model coverage

PARABanzai International, Inc.QOC 4.3GDLGGlidelogic Corp.QOC 4.1LIVGLivento Group, Inc.QOC 4.3BLIVBeLive HoldingsQOC 4.1ILLRTriller Group Inc.QOC 4.3OCTVOctave Intelligence plcQOC 4.0DCBODocebo Inc.QOC 9.0MNDYmonday.com Ltd.QOC 7.4BZAIBlaize Holdings, Inc.QOC 6.1ADSKAutodesk, Inc.QOC 9.9PTCPTC Inc.QOC 9.8

Read investment analysis: PARA · GDLG · LIVG · BLIV · ILLR · OCTV · DCBO · MNDY · BZAI · ADSK · PTC

Which Other Stocks Have a Similar Quality Score to LMED?

7 companies across all industries closest to LMED’s Quality of Company score of 4.2/10.

ANVIAnvi Global Holdings, Inc.QOC 4.2DSSDSS, Inc.QOC 4.2APVOAptevo Therapeutics Inc.QOC 4.2NSTMNovelStem International Corp.QOC 4.2MEDSDataMEDS AI, Inc.QOC 4.2CPWROcean Thermal Energy CorporationQOC 4.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: ANVI · DSS · APVO · NSTM · MEDS · CPWR · NVDA

Where Does LMED Sit in CirclFi's Software - Application Rankings?

LMED is ranked against every other Software - Application stock CirclFi covers in each of these screens.

See all Software - Application stocks ranked →

What Else Do Investors Ask About LataMed AI Corp.’s Valuation?

What is LataMed AI Corp.'s intrinsic value in 2026?

CirclFi puts LataMed AI Corp. (LMED)'s intrinsic value at $0.01 — the median of 2 independent model estimates as of 2026-10-07, ranging from $0.00 to $0.01. The Quality of Company score is 4.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LMED overvalued or undervalued right now?

At $0.06, 0 of 2 active models suggest LMED may be undervalued, while 2 indicate potential overvaluation. The median of all 2 fair value estimates is $0.01, 87.6% below the current price of $0.06 — a consensus view that LMED is overvalued. The assessment depends on which methodology best fits LataMed AI Corp.'s business model in Software - Application.

What does a Quality of Company score of 4.2 mean for LMED?

LataMed AI Corp.'s QOC of 4.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on LMED?

CirclFi analyzes LMED with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is LMED a value trap in 2026?

LataMed AI Corp.'s Value Trap score is 36/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, LataMed AI Corp. (LMED) has a median fair value of $0.01 — 87.6% below the current price of $0.06 — as of 2026-10-07.” Source: circlfi.com/stock/LMED/ · Methodology
Primary sources for this LMED valuation
  • Financial statements: LataMed AI Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001477960) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for LMED as of ; valuations recomputed .